Medicare Enrolled
Florida Board Action on Record
The Florida Department of Health has flagged this practitioner's license with a board action.
Verify on FL DOH →
Dr. Carlos Ramirez-Calderon, M.D.
Neurology · Miami, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ramirez-Calderon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ramirez-Calderon?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ramirez-Calderon
Dr. Carlos Ramirez-Calderon is a neurology specialist in Miami, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ramirez-Calderon performed 523 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Ramirez-Calderon received a total of $120,844 from 67 pharmaceutical and/or device companies across 1493 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ramirez-Calderon is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 48% volume in FL
$120,844 industry payments
Florida License Status
FL DOH · MQA1
Active license
Yes
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 47383 | Clear | January 31, 2028 | ⚠ |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗523
Medicare services
Top 48% in FL for neurology
Not available
Unique patients (not deduplicated)
$92
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
217 | $138 | $788 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
48 | $92 | $562 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
45 | $12 | $73 |
| New patient office visit, complex (60-74 min) | 41 | $160 | $976 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
39 | $11 | $60 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
36 | $107 | $626 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
33 | $23 | $132 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
28 | $1 | $4 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
18 | $74 | $453 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
18 | $4 | $24 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
6.9% high complexity
31.2% medium
62.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$120,844
Total received (2018-2024)
Avg $17,263/year across 7 years
Top 5% in FL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
1,493
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,935
2023
$4,855
2022
$6,033
2021
$5,148
2020
$7,487
2019
$35,406
2018
$56,980
Payments by company (2024)
EMD Serono, Inc.
$489
Eisai Inc.
$485
Novartis Pharmaceuticals Corporation
$484
Mallinckrodt Hospital Products Inc.
$381
Neurocrine Biosciences, Inc.
$351
ABBVIE INC.
$316
Lundbeck LLC
$288
TG Therapeutics, Inc.
$281
Lilly USA, LLC
$220
BANNER LIFE SCIENCES, LLC
$211
UCB, Inc.
$166
ARGENX US, INC.
$159
Biogen, Inc.
$144
Amneal Pharmaceuticals LLC
$122
GE HEALTHCARE
$105
Teva Pharmaceuticals USA, Inc.
$100
Genentech USA, Inc.
$98
Neurelis, Inc.
$90
Otsuka America Pharmaceutical, Inc.
$77
Kyowa Kirin, Inc.
$77
SK Life Science, Inc.
$46
MDD US Operations, LLC
$40
Amgen Inc.
$35
GENZYME CORPORATION
$34
AstraZeneca Pharmaceuticals LP
$32
InSightec,Inc
$31
MITSUBISHI TANABE PHARMA AMERICA, INC.
$24
Acorda Therapeutics, Inc
$22
Alexion Pharmaceuticals, Inc.
$14
Celgene Corporation
$13
Top 3 companies account for 29.6% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$56,960
Biogen, Inc.
$24,107
Genentech USA, Inc.
$9,168
Novartis Pharmaceuticals Corporation
$6,429
EMD Serono, Inc.
$3,014
Acorda Therapeutics, Inc
$2,827
Mallinckrodt Hospital Products Inc.
$1,529
UCB, Inc.
$1,338
Neurocrine Biosciences, Inc.
$1,082
Banner Life Sciences, LLC
$927
ABBVIE INC.
$915
Alexion Pharmaceuticals, Inc.
$812
Adamas Pharmaceuticals, Inc.
$803
Amneal Pharmaceuticals LLC
$751
Teva Pharmaceuticals USA, Inc.
$646
SK Life Science, Inc.
$635
Eisai Inc.
$607
Janssen Pharmaceuticals, Inc
$548
Lilly USA, LLC
$547
Kyowa Kirin, Inc.
$470
Lundbeck LLC
$416
BANNER LIFE SCIENCES, LLC
$370
AbbVie Inc.
$354
Sunovion Pharmaceuticals Inc.
$345
GE HEALTHCARE
$329
Celgene Corporation
$323
ARGENX US, INC.
$315
TG Therapeutics, Inc.
$281
Allergan, Inc.
$256
Mallinckrodt Enterprises LLC
$249
Corium, LLC
$228
PFIZER INC.
$202
Mallinckrodt LLC
$201
Vertical Pharmaceuticals, LLC
$193
GE HealthCare
$189
E.R. Squibb & Sons, L.L.C.
$184
Avion Pharmaceuticals
$173
Horizon Therapeutics plc
$169
Neurelis, Inc.
$163
TG THERAPEUTICS, INC.
$147
Otsuka America Pharmaceutical, Inc.
$144
US WorldMeds, LLC
$143
Supernus Pharmaceuticals, Inc.
$119
GRT US Holding, Inc.
$108
Biohaven Pharmaceutical Holding Company Ltd.
$94
Biohaven Pharmaceuticals, Inc.
$91
MITSUBISHI TANABE PHARMA AMERICA, INC.
$90
ACADIA Pharmaceuticals Inc
$87
Amgen Inc.
$85
EISAI INC.
$76
Avanir Pharmaceuticals, Inc.
$62
Octapharma USA, Inc.
$58
AstraZeneca Pharmaceuticals LP
$54
ANI Pharmaceuticals, Inc.
$51
Upsher-Smith Laboratories LLC
$48
Abbott Laboratories
$47
Bayer HealthCare Pharmaceuticals Inc.
$42
MDD US Operations, LLC
$40
CATALYST PHARMACEUTICALS, INC.
$33
InSightec,Inc
$31
Ipsen Biopharmaceuticals, Inc
$28
Exeltis, USA Inc.
$24
Mitsubishi Tanabe Pharma America, Inc.
$23
Bausch Health US, LLC
$22
Allergan Inc.
$21
Impax Laboratories, Inc.
$13
SANOFI-AVENTIS U.S. LLC
$7
Top 3 companies account for 74.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Apokyn · Austedo XR · BAFIERTAM · BOTOX · BRIUMVI · Betaseron · Briviact · COLOGUARD DNA CAPTURE REAGENTS · COPAXONE · DISEASE STATE · DIVIGEL · DUOPA · DaTscan · Dhivy · Dysport · EMGALITY · EVUSHELD · Exablate · FIRDAPSE · Fycompa · GILENYA · GOCOVRI · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NO PRODUCT DISCUSSED · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · OCREVUS · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PLEGRIDY · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Qutenza · RADICAVA · REXULTI · REYVOW · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPINRAZA · Soliris · TECFIDERA · TOPIRAMATE Extended Release Capsules · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XCOPRI · Xadago · ZEPOSIA · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
220
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
BAPTIST HOSPITAL OF MIAMI
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ramirez-Calderon is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ramirez-Calderon experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Ramirez-Calderon performed 217 office visit, established patient, complex (40-54 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ramirez-Calderon receive payments from pharmaceutical companies?
Yes. Dr. Ramirez-Calderon received a total of $120,844 from 67 companies across 1,493 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ramirez-Calderon's costs compare to other neurologists in Miami?
Dr. Ramirez-Calderon's average Medicare payment per service is $92. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ramirez-Calderon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Miami
Browse neurologists in Miami ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in FL
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in FL
Which FL neurologists receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology